TP53 and cancer: In recent years, a growing number of large cohorts have shown cancer patients found to be carriers of TP53 pathogenic or likely pathogenic variants, who did not present with classical features of LFS, had late onset of cancer or cancers not previously associated with LFS and little or no family history of cancer [7–9].